[1]崔岩 刘志强 吴艳刚.应用两种骨水泥治疗骨质疏松性椎体压缩骨折的骨密度差异[J].中国中医骨伤科杂志,2020,28(01):28-34.
　CUI Yan LIU Zhiqiang WU Yangang.Difference of Bone Mineral Density between Two Kinds of Bone Cement in Treating Osteoporotic Vertebral Compressed Fractures[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2020,28(01):28-34.
点击复制

应用两种骨水泥治疗骨质疏松性椎体压缩骨折的骨密度差异()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第28卷
期数:
2020年01期
页码:
28-34
栏目:
临床研究
出版日期:
2020-01-15

文章信息/Info

Title:
Difference of Bone Mineral Density between Two Kinds of Bone Cement in Treating Osteoporotic Vertebral Compressed Fractures
文章编号:
1005-0205(2020)01-0028-07
作者:
崔岩1 刘志强1 吴艳刚1
1北京市顺义区医院骨一科(北京,101300)
Author(s):
CUI Yan1 LIU Zhiqiang1 WU Yangang1
1Department of Orthopedics,Shunyi District Hospital,Beijing 101300,China.
关键词:
椎体成形术;  磷酸钙骨水泥;  重组人骨形态发生蛋白2;  骨质疏松性椎体压缩骨折
Keywords:
vertebroplasty;  calcium phosphate cement;  recombinant human bone morphogenetic protein 2;  osteoporotic vertebral compressed fracture
分类号:
R683.2
文献标志码:
A
摘要:
目的:分析复合重组人骨形态发生蛋白2的磷酸钙骨水泥与单独磷酸钙骨水泥治疗骨质疏松性椎体压缩骨折的骨密度差异。方法:选取骨质疏松性椎体压缩骨折患者132例,其中68例患者采用磷酸钙骨水泥(磷酸钙组)治疗,另64例采用复合重组人骨形态发生蛋白的2磷酸钙骨水泥(磷酸钙联合生长因子组)治疗。术后7 d,门诊随访观察临床疗效; 术前及术后3个月和6个月,采用双能X线骨密度仪检测伤椎骨密度及屏蔽填充物注射区伤椎骨密度; 术前、术后7 d、术后3个月及末次随访时,用目测类比评分评估患者腰背部疼痛情况,采用Oswestry功能障碍指数评估脊柱功能,X线观察伤椎椎体前缘高度及后凸角。结果:两种治疗方式均取得了良好的治疗效果,总治疗有效率差异无统计学意义(P>0.05); 末次随访时,磷酸钙联合生长因子组临近椎体骨折发生明显少于磷酸钙组,差异有统计学意义(P<0.05); 术后6个月,磷酸钙联合生长因子组骨密度值明显高于术前及磷酸钙组,差异有统计学意义(P<0.05); 两组术后不同时间点的疼痛、脊柱功能均较术前明显改善,差异有统计学意义(P<0.05),两组间比较差异无统计学意义(P>0.05); 两组术后不同时间点的伤椎椎体前缘高度及后凸角均较术前明显改善,差异有统计学意义(P<0.05),两组间比较差异无统计学意义(P>0.05)。结论:对比单独磷酸钙骨水泥,复合重组人骨形态发生蛋白2的磷酸钙骨水泥治疗骨质疏松性椎体压缩骨折可提高骨密度,阻止邻近椎体发生骨折。
Abstract:
Objective:Comparison of bone mineral density difference between compound recombinant human bone morphogenetic protein 2 calcium phosphate cement and calcium phosphate cement alone in treating of osteoporotic vertebral compressed fractures(OVCF).Methods:132 patients with OVCF were enrolled,68 patients underwent treatment with calcium phosphate cement combined(calcium phosphate group),and 64 patients with compound recombinant human bone morphogenetic protein 2 calcium phosphate cement combined.Outpatient follow-up was conducted to observe the clinical efficacy 7 d after operation.Dual-energy X-ray bone mineral density instrument was used to measure the bone mineral density of injured vertebrae and the bone mineral density of injured vertebrae in the injection area of shielding filler before,3 and 6 months after operation.Visual Analogy Score(VAS)was used to evaluate the lumbar and back pain of patients,and Oswestry Disability Index was used to evaluate spinal function,and X-ray was used to observe the height and kyphosis angle of the vertebral body at all follow-up.Results:There was no significant difference in the total effective rate between the two groups(P>0.05).At the last follow-up,the incidence of adjacent vertebral fracture in calcium phosphate combined with growth factor group was significantly less than that in calcium phosphate group(P<0.05).The bone mineral density value of calcium phosphate combined with growth factor group was significantly higher than that of preoperative and calcium phosphate group 6 months later(P<0.05).The pain and spinal function of two groups at different time points after operation were significantly improved compared with those before operation(P<0.05),and there was no significant difference between the two groups.The anterior height and kyphosis angle of injured vertebral body at different time points after operation were both higher than those before operation.Conclusion:Compared with calcium phosphate cement alone,calcium phosphate cement combined with recombinant human bone morphogenetic protein 2 can improve bone mineral density and prevent adjacent vertebral fractures in treating OVCF.

参考文献/References:

[1] BOZKURT M,KAHILOGULLARI G,OZDEMIR M,et al.Comparative analysis of vertebroplasty and kyphoplasty for osteoporotic vertebral compression fractures[J].Asian Spine,2014,8(1):27-34.
[2] 何江涛,王三木,李众毅.经横突-椎弓根单侧穿刺骨水泥注射椎体成形治疗胸腰椎骨质疏松性椎体压缩骨折[J].中国组织工程研究,2019,23(22):3604-3608.
[3] 肖运祥,陈海丹,刘杨.PVP一期治疗多节段骨质疏松性椎体压缩骨折的疗效和安全性观察[J].中国骨与关节损伤杂志,2018,33(3):236-239.
[4] 贾其余,胡联英,俞宇,等.球囊扩张椎体成形结合短节段椎弓根螺钉固定治疗胸腰椎爆裂性骨折[J].中国修复重建外科杂志,2015,29(6):741-745.
[5] 邓红军.硫酸钙骨水泥椎体成形联合后路短节段椎弓根螺钉内固定治疗创伤性胸腰椎骨折[J].中医正骨,2015,27(10):35-37.
[6] 董国领,贾璞,唐海.可吸收骨水泥在椎体强化术中的应用[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(3):292-297.
[7] 徐建民,王兆朋,王恒孝.骨形态发生蛋白-2在兔骨折愈合过程中的作用[J].中国矫形外科杂志,2016,24(10):920-925.
[8] 《原发性骨质疏松症诊疗社区指导原则》编写组.原发性骨质疏松症社区诊疗指导原则[J].中国全科医学,2019,22(10):1125-1132.
[9] 张宏志.椎体成形联合Schanz 螺钉治疗骨质疏松性胸腰段椎体压缩骨折的疗效分析[J].创伤外科杂志,2018,20(4):297-300.
[10] GALIBERT P,DERAMOND H,ROSAT P,et al.Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty[J].Neurochirurgie,1987,33(2):166-168.
[11] LIANG L,CHEN X,JIANG W,et al.Balloon kyphoplasty or percutaneous vertebroplasty for osteoporotic vertebral compression fracture? An updated systematic review and meta-analysis[J].Ann Saudi Med,2016,36(3):165-174.
[12] YALTIRIK K,ASHOUR A M,REIS C R,et al.Vertebral augmentation by kyphoplasty and vertehmplasty:8 years experience outodmes and complications[J].J Craniovertebr Junction Spine,2016,7(3):153-160.
[13] 郭丹青,陈林威,于淼,等.椎体强化术治疗骨质疏松性椎体压缩骨折临床疗效的meta分析[J].中国中医骨伤科杂志,2014,22(5):21-25.
[14] 丁凯,丁文鸽,凌为其.经皮椎体成形术与非手术治疗中老年骨质疏松性椎体压缩骨折的疗效分析[J].中国老年学杂志,2017,37(24):6137-6139.
[15] 钟睿,姜威,熊森,等.单侧弯角与直行入路椎体成形治疗骨质疏松性椎体压缩骨折疗效的对照研究[J].中华创伤杂志,2018,34(2):102-108.
[16] 卢昌怀,刘志军,张宏波,等.单侧与双侧PVP治疗骨质疏松性胸腰椎压缩性骨折疗效分析[J].中国中医骨伤科杂志,2015,23(4):23-25.
[17] SUN Z Y,LI X F,ZHAO H,et al.Percutaneous balloon kyphoplasty in treatment of painful osteoporotic occult vertebral fracture:a retrospective study of 89 cases[J].Med Sci Monit,2017,7(23):1682-1690.
[18] LI Q L,LI X Z,LIU Y,et al.Treatment of thoracolumbar fracture with pedicle screws at injury level:a biomechanical study based on three-dimensional finite element analysis[J].Eur Orthop Surg Traumatol,2013,23(7):775-780.
[19] LOIB M,KORSUN M,REISS J,et al.Spinal fracture reduction with a minimal-invasive transpedicular Schanz Screw system:clinical and radiological one-year follow-up[J].Injury,2015,46(4):75-82.
[20] 杨泽雨,阮建伟,郑文标,等.PVP和PKP骨水泥填充材料的研究进展[J].医学综述,2017,23(15):3008-3011.
[21] 付来华,汉华,宋建民,等.骨形态发生蛋白-2在骨科的研究进展[J].甘肃医药,2014,33(10):762-765.
[22] 王新虎,张军,刘夏君,等.经皮椎体成形术与经皮椎体后凸成形术骨水泥渗漏原因分析及对策[J].华西医学,2015,30(4):648-651.

备注/Memo

备注/Memo:
(收稿日期:2019-06-17)
更新日期/Last Update: 2020-01-15